Interactions between the body's immune system and bacteria that live in the gut become disrupted in multiple sclerosis (MS), ...

A sponge-like implant in mice helped guide a treatment that slowed or stopped a degenerative condition similar to multiple sclerosis in humans. It also gave University of Michigan researchers a first ...

The gut microbiome comprises the trillions of bacteria and other microorganisms that live in our digestive tracts, and it has ...

A Yale University study uncovers how gut bacteria imbalances may trigger multiple sclerosis (MS), offering new insights into ...

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system caused by the immune system. B cells, ...

Ocrevus as a first-line treatment for early relapsing MS is better at delaying disease progression than starting with a less ...

Discontinuation of first-line DMTs among patients with stable MS for at least 5 years may lead to an increased risk for recurrence.

Prenatal and early life sun exposure is associated with a lower risk for relapse in childhood-onset MS, new findings suggest, ...

A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis (MS) in Finland between 2013 and 2022. According to the study, MS treatment ...